| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-30,608 | -21,846 | -16,259 | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Share-based compensation expense | ||||||
3,083 | 1,023 | 515 | ||||
Depreciation and amortization | ||||||
960 | 712 | 332 | ||||
Change in fair value of warrant liability | ||||||
5,381 | 665 | 119 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
-4,909 | 400 | - | ||||
Non-cash research and development expense | ||||||
- | - | 856 | ||||
Research and development incentives receivable | ||||||
383 | 3,586 | 1,407 | ||||
Prepaid expenses and other current assets | ||||||
2,723 | 1,329 | 330 | ||||
Operating lease right-of-use assets | ||||||
-712 | - | - | ||||
Other assets | ||||||
397 | 301 | 1,039 | ||||
Accounts payable | ||||||
220 | -169 | 67 | ||||
Accrued expenses and other current liabilities | ||||||
-852 | 2,557 | 1,267 | ||||
Lease liabilities | ||||||
-709 | - | - | ||||
Deferred revenue | ||||||
-9,295 | -3,947 | 14,081 | ||||
Other long-term liabilities | ||||||
1,089 | 543 | 383 | ||||
Net cash provided by (used in) operating activities | ||||||
-28,613 | -26,078 | -1,415 | ||||
Cash used in investing activities: | ||||||
Purchases of property and equipment | ||||||
1,555 | 1,186 | 1,113 | ||||
Net cash used in investing activities | ||||||
-1,555 | -1,186 | -1,113 | ||||
Cash flows from financing activities: | ||||||
Proceeds from issuance of ADSs in initial public offering, net of issuance costs | ||||||
56,957 | -576 | - | ||||
Proceeds from the exercise of share options and sale of ordinary shares | ||||||
143 | 1 | 1 | ||||
Proceeds from the exercise of warrants | ||||||
6 | - | - | ||||
Net cash provided by financing activities | ||||||
58,440 | 25,430 | 57,876 | ||||
Effect of exchange rate changes on cash | ||||||
465 | -2,449 | 2,913 | ||||
Net increase (decrease) in cash | ||||||
28,737 | -4,283 | 58,261 | ||||
Supplemental disclosure of cash flow information | ||||||
Cash paid for income taxes | ||||||
117 | 73 | - | ||||
Cash paid for amounts included in the measurement of operating lease liabilities | ||||||
891 | - | - | ||||
Purchases of property and equipment included in accounts payable and accrued expenses | ||||||
76 | - | - | ||||
Advance billings on deferred revenue included in accounts receivable | ||||||
- | 5,045 | - | ||||
Deferred initial public offering costs accrued but not paid | ||||||
- | 1,076 | - | ||||
Conversion of convertible preferred shares to ordinary shares upon closing of the initial public offering | ||||||
123,780 | - | - | ||||
Reclassification of warrant liability to additional paid-in capital | ||||||
10,021 | - | - | ||||
Series B1 Convertible Preferred Shares | ||||||
Proceeds from issuance of convertible preferred shares, net of issuance costs | ||||||
- | - | 57,875 | ||||
Series B2 Convertible Preferred Shares | ||||||
Proceeds from issuance of convertible preferred shares, net of issuance costs | ||||||
1,334 | 26,005 | - | ||||
Series B2 convertible preferred financing costs accrued but not paid | ||||||
- | 249 | - | ||||